-
TRANSFORMING VACCINE AVAILABILITY THROUGH REAL-TIME LAST-MILE VISIBILITY: A SYSTEMS APPROACH TO STRENGTHENING STOCK DATA IN NIGERIAN PHC FACILITIES
Feb 25, 2026, 14:41 PM -
COMPARING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2I) VERSUS RENIN-ANGIOTENSIN SYSTEM INHIBITOR (RASI) IN HEART FAILURE PATIENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIA (ADRD)
Feb 25, 2026, 14:41 PM -
DOES HEALTH EXPENDITURE BUILD TRUST? EVIDENCE FROM OECD COUNTRIES, 2010-2022
Feb 25, 2026, 14:41 PM -
AN ONTOLOGY-INFORMED STRATEGY FOR MEDICATION INTEROPERABILITY IN REAL-WORLD DATA: FROM ANALYTIC FEASIBILITY TO CONCEPTUAL FOUNDATIONS
Feb 25, 2026, 14:41 PM -
REAL-WORLD DISEASE ACTIVITY AND TREATMENT RESPONSIVENESS AMONG ADULTS WITH RHEUMATOID ARTHRITIS
Feb 25, 2026, 14:41 PM -
THE COST-EFFECTIVENESS OF INCLUSION OF JERYL LYNN MUMPS VACCINE IN THE MEASLES-RUBELLA ROUTINE IMMUNISATION SCHEDULE AMONG CHILDREN IN INDIA
Feb 25, 2026, 14:41 PM -
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH =2 LINES OF THERAPY (LOTS) FOR RECURRENT OR PROGRESSIVE ENDOMETRIAL CANCER
Feb 25, 2026, 14:41 PM -
IDENTIFYING (DIS-)AGREEMENT BETWEEN MODELS FOR EVALUATION OF EFFECTIVENESS OF RISK MINIMIZATION MEASURES (RMMS)
Feb 25, 2026, 14:41 PM -
IMPLEMENTATION OF EU JOINT CLINICAL ASSESSMENT: AN EARLY LANDSCAPE OF SUBMISSION PATTERNS AND HTA INVOLVEMENT
Feb 25, 2026, 14:41 PM -
EVALUATING MARGINAL HEALTHCARE EXPENDITURESACROSS DEMOGRAPHIC SUBGROUPS IN DEMENTIA USING BAYESIAN HIERARCHICAL MODELS
Feb 25, 2026, 14:41 PM -
SOCIETAL IMPACT ASSESSMENT OF RIBOCICLIB FOR HR+/HER2- ADVANCED BREAST CANCER: INTEGRATING HUMAN CAPITAL AND UNPAID WORK VALUATION USING INPUT-OUTPUT ANALYSIS
Feb 25, 2026, 14:41 PM -
THE IMPACT OF CHRONIC KIDNEY DISEASE AND ANEMIA ON THE ASSOCIATION BETWEEN FASTING PLASMA GLUCOSE AND HBA1C LEVELS
Feb 25, 2026, 14:41 PM -
EXPLANATION AND ELABORATION OF THE DEEM-Q CHECKLIST: GUIDANCE FOR ASSESSING THE METHODOLOGICAL QUALITY OF ECONOMIC EVALUATIONS OF MEDICAL DEVICES
Feb 25, 2026, 14:41 PM -
COMMON VS FREQUENT: ASSESSING VARIABLE DISEASE PRESENTATION IN IGAN AND C3G, THROUGH HOME-REPORTED OUTCOMES AND PATIENT-REPORTED ENDPOINTS ANALYSES
Feb 25, 2026, 14:41 PM -
EXAMINING THE ASSOCIATION BETWEEN PROBLEMATIC INTERNET USE AND MENTAL HEALTH AMONG ADOLESCENTS
Feb 25, 2026, 14:41 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Feb 25, 2026, 14:41 PM -
LIVER SAFETY COMPARISON OF BEMIPARIN AND ENOXAPARIN IN PREGNANCY: INSIGHTS FROM A REAL-WORLD STUDY
Feb 25, 2026, 14:41 PM -
PATIENT-REPORTED OUTCOMES-BASED SYMPTOM MONITORING AMONG PATIENTS RECEIVING IMMUNOTHERAPY FOR LUNG CANCER: A RANDOMIZED CONTROLLED TRIAL
Feb 25, 2026, 14:41 PM -
MEASUREMENT OF PREVALENCE AND INCIDENCE IN OPEN CLAIMS DATA: ASSESSMENT OF DIFFERENT METHODOLOGIES
Feb 25, 2026, 14:41 PM -
PREVALENCE, RISK FACTORS, AND SAFETY IMPLICATIONS OF POTENTIALLY INAPPROPRIATE MEDICATION USE AMONG OLDER ADULTS WITH DEMENTIA: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:41 PM
